Cash flow ALK-Abelló A/S

Stocks

ALK B

DK0061802139

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 10/07/2026 BST			5-day change	1st Jan Change
242.60 ^DKK	-0.25%		-0.57%	+6.12%

06-15	ALK Receives UK Approval For EURneffy 1 Mg As The First And Only Needle-Free Adrenaline Treatment For Young Children At Risk Of Anaphylaxis	CI
06-15	UK Regulator OKs Lower Dose of ALK-Abelló's Severe Allergic Reaction Treatment	MT

511b2c2bb986aa51d5772d.1RZA3HjkSZZGmCoQCOp77jCWZB39c9I-HtgaMP-OIcc.ukAO7Qq9eP4f1F9AOd4Su3H9VHOaJOpxXOpFRbn_ErO9WQy9IIY6_DLcXQ

Published financial data: ALK-ABELLÓ A/S

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	3.92B	4.51B	4.82B	5.54B	6.31B
Total Revenues	3.92B	4.51B	4.82B	5.54B	6.31B
Cost of Goods Sold, Total	1.51B	1.69B	1.79B	1.98B	2.07B
Gross Profit	2.4B	2.82B	3.04B	3.56B	4.24B
Selling General & Admin Expenses, Total	1.46B	1.66B	1.75B	1.93B	1.97B
Stock-Based Compensation (IS)	1M	-	-	-	-
R&D Expenses	630M	665M	618M	531M	609M
Other Operating Expenses	-1M	-1M	-2M	-3M	-1M
Other Operating Expenses, Total	2.09B	2.32B	2.37B	2.46B	2.58B
Operating Income	311M	502M	667M	1.1B	1.66B
Interest Expense, Total	-23M	-24M	-22M	-65M	-31M
Interest And Investment Income	1M	4M	12M	61M	28M
Net Interest Expenses	-22M	-20M	-10M	-4M	-3M
Currency Exchange Gains (Loss)	9M	-3M	-9M	-30M	-16M
Other Non Operating Income (Expenses)	1M	-	-	-	-
EBT, Excl. Unusual Items	299M	479M	648M	1.06B	1.64B
Restructuring Charges	-	-1M	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-20M	-1M	-1M	-6M	-10M
Other Unusual Items	-	-30M	-	-	-
EBT, Incl. Unusual Items	279M	447M	647M	1.06B	1.64B
Income Tax Expense	60M	112M	161M	242M	438M
Earnings From Continuing Operations	219M	335M	486M	815M	1.2B
Net Income to Company	219M	335M	486M	815M	1.2B
Net Income - (IS)	219M	335M	486M	815M	1.2B
Net Income to Common Incl Extra Items	219M	335M	486M	815M	1.2B
Net Income to Common Excl. Extra Items	219M	335M	486M	815M	1.2B
Per Share Items
Net EPS - Basic	1	1.52	2.2	3.68	5.4
Basic EPS - Continuing Operations	1	1.52	2.2	3.68	5.4
Basic Weighted Average Shares Outstanding	219M	221M	221M	221M	222M
Net EPS - Diluted	0.99	1.51	2.2	3.68	5.4
Diluted EPS - Continuing Operations	0.99	1.51	2.2	3.68	5.4
Diluted Weighted Average Shares Outstanding	221M	221M	221M	222M	222M
Normalized Basic EPS	0.85	1.36	1.83	3	4.64
Normalized Diluted EPS	0.85	1.35	1.83	3	4.64
Dividend Per Share	-	-	-	-	1.6
Payout Ratio	-	-	-	-	-
American Depositary Receipts Ratio (ADR)	0.2	0.2	0.2	0.2	0.2
Supplemental Items
EBITDA	461M	667M	834M	1.28B	1.9B
EBITA	318M	512M	675M	1.11B	1.72B
EBIT	311M	502M	667M	1.1B	1.66B
EBITDAR	481M	687M	857M	1.3B	1.92B
Effective Tax Rate - (Ratio)	21.51	25.06	24.88	22.89	26.79
Total Current Taxes	157M	94M	94M	219M	203M
Total Deferred Taxes	-97M	18M	67M	23M	249M
Normalized Net Income	187M	299M	405M	664M	1.03B
Interest on Long-Term Debt	7M	6M	7M	9M	9M
Non-Cash Pension Expense	2M	3M	6M	6M	6M
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.22B	1.38B	1.42B	1.56B	1.58B
General and Administrative Expenses	240M	276M	331M	369M	388M
Research And Development Expense From Footnotes	631M	665M	618M	531M	609M
Net Rental Expense, Total	20M	20M	23M	21M	24M
Imputed Operating Lease Interest Expense	4.45M	5.46M	5.54M	11.19M	7.42M
Imputed Operating Lease Depreciation	15.55M	14.54M	17.46M	9.81M	16.58M
Stock-Based Comp., COGS (Total)	5M	4M	6M	10M	9M
Stock-Based Comp., R&D Exp. (Total)	7M	7M	6M	9M	8M
Stock-Based Comp., S&M Exp. (Total)	11M	8M	9M	13M	12M
Stock-Based Comp., G&A Exp. (Total)	12M	8M	9M	16M	16M
Stock-Based Comp., Other (Total)	1M	-	-	3M	-
Total Stock-Based Compensation	36M	27M	30M	51M	45M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	194M	221M	474M	589M	1.24B
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	194M	221M	474M	589M	1.24B
Accounts Receivable, Total	583M	764M	816M	812M	1.09B
Other Receivables	108M	124M	108M	59M	246M
Total Receivables	691M	888M	924M	871M	1.34B
Inventory	1.2B	1.3B	1.42B	1.72B	1.78B
Prepaid Expenses	314M	239M	147M	118M	132M
Total Current Assets	2.4B	2.64B	2.97B	3.29B	4.49B
Gross Property Plant And Equipment	3.24B	3.58B	3.89B	4.22B	4.26B
Accumulated Depreciation	-1.43B	-1.56B	-1.71B	-1.88B	-2B
Net Property Plant And Equipment	1.81B	2.02B	2.18B	2.35B	2.26B
Long-term Investments	-	-	-	-	-
Goodwill	457M	460M	459M	463M	455M
Other Intangibles, Total	165M	182M	212M	1.33B	1.31B
Deferred Tax Assets Long-Term	790M	716M	659M	642M	353M
Other Long-Term Assets, Total	201M	287M	247M	171M	181M
Total Assets	5.83B	6.31B	6.73B	8.25B	9.06B
Liabilities
Accounts Payable, Total	115M	131M	128M	165M	140M
Accrued Expenses, Total	797M	739M	670M	692M	886M
Current Portion of Long-Term Debt	244M	226M	280M	690M	17M
Current Portion of Leases	37M	41M	46M	46M	46M
Current Income Taxes Payable	23M	16M	17M	124M	39M
Unearned Revenue Current, Total	4M	4M	4M	4M	11M
Other Current Liabilities	165M	242M	169M	228M	190M
Total Current Liabilities	1.38B	1.4B	1.31B	1.95B	1.33B
Long-Term Debt	222M	203M	184M	166M	151M
Long-Term Leases	207M	226M	255M	285M	204M
Unearned Revenue Non Current	42M	49M	46M	45M	277M
Pension & Other Post Retirement Benefits	324M	236M	245M	251M	244M
Deferred Tax Liability Non Current	1M	4M	4M	3M	238M
Other Non Current Liabilities	169M	203M	231M	174M	169M
Total Liabilities	2.35B	2.32B	2.28B	2.87B	2.61B
Common Stock, Total	111M	111M	111M	111M	111M
Retained Earnings	3.41B	3.86B	4.35B	5.2B	6.44B
Comprehensive Income and Other	-41M	20M	-18M	65M	-103M
Total Common Equity	3.48B	3.99B	4.45B	5.37B	6.44B
Total Equity	3.48B	3.99B	4.45B	5.37B	6.44B
Total Liabilities And Equity	5.83B	6.31B	6.73B	8.25B	9.06B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	220M	221M	221M	221M	222M
ECS Total Common Shares Outstanding	220M	221M	221M	221M	222M
Book Value / Share	15.83	18.05	20.1	24.29	29.09
Tangible Book Value	2.86B	3.35B	3.78B	3.58B	4.68B
Tangible Book Value Per Share	13	15.14	17.07	16.19	21.12
Total Debt	710M	696M	765M	1.19B	418M
Net Debt	516M	475M	291M	598M	-822M
Debt Equivalent of Unfunded Proj. Benefit Obligation	254M	164M	173M	176M	167M
Debt Equivalent Oper. Leases	160M	160M	184M	168M	192M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	245M	265M	307M	405M	405M
Inventories - Work In Process, Total	432M	507M	637M	649M	698M
Inventories - Finished Goods, Total	527M	525M	479M	662M	680M
Land - (BS)	1.29B	1.35B	1.36B	1.51B	1.5B
Machinery, Total	1.29B	1.32B	1.48B	1.67B	1.77B
Full Time Employees	2.54K	2.68K	2.82K	2.75K	2.61K
Accumulated Allowance for Doubtful Accounts (Supple)	11M	8M	7M	16M	6M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	219M	335M	486M	815M	1.2B
Depreciation & Amortization - CF	181M	198M	206M	218M	229M
Amortization of Goodwill and Intangible Assets - (CF)	7M	10M	8M	16M	55M
Depreciation & Amortization, Total	188M	208M	214M	234M	284M
Amortization of Deferred Charges, Total - (CF)	34M	28M	30M	32M	34M
(Gain) Loss From Sale Of Asset	33M	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	20M	2M	1M	6M	10M
Stock-Based Compensation (CF)	36M	27M	30M	51M	45M
Other Operating Activities, Total	-34M	51M	109M	226M	396M
Change In Accounts Receivable	-5M	-172M	-69M	78M	-389M
Change In Inventories	-84M	-74M	-132M	-272M	-126M
Change In Accounts Payable	61M	11M	-2M	43M	366M
Cash from Operations	468M	416M	667M	1.21B	1.82B
Capital Expenditure	-218M	-298M	-310M	-260M	-276M
Cash Acquisitions	-	-	-	-115M	-10M
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-45M	-55M	-69M	-1.04B	-84M
Investment in Marketable and Equity Securities, Total	-3M	2M	4M	1M	-15M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-266M	-351M	-375M	-1.42B	-385M
Long-Term Debt Issued, Total	226M	60M	671M	671M	-
Total Debt Issued	226M	60M	671M	671M	-
Long-Term Debt Repaid, Total	-496M	-133M	-682M	-329M	-734M
Total Debt Repaid	-496M	-133M	-682M	-329M	-734M
Issuance of Common Stock	31M	42M	-	6M	-
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-72M	-11M	-20M	-38M	-26M
Cash from Financing	-311M	-42M	-31M	310M	-760M
Foreign Exchange Rate Adjustments	5M	4M	-8M	9M	-21M
Net Change in Cash	-104M	27M	253M	115M	651M
Supplemental Items
Cash Interest Paid	23M	14M	23M	13M	51M
Cash Income Tax Paid (Refund)	100M	78M	60M	95M	81M
Levered Free Cash Flow	133M	21.75M	84.12M	-327M	528M
Unlevered Free Cash Flow	147M	36.75M	97.88M	-286M	547M
Change In Net Working Capital	42M	187M	214M	-14M	496M
Net Debt Issued / Repaid	-270M	-73M	-11M	342M	-734M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.41	5.17	6.4	9.16	12.02
Return on Total Capital	4.69	7.07	8.43	11.65	15.5
Return On Equity %	6.6	8.97	11.52	16.6	20.26
Return on Common Equity	6.6	8.97	11.52	16.6	20.26
Margin Analysis
Gross Profit Margin %	61.36	62.56	62.94	64.26	67.24
SG&A Margin	37.33	36.71	36.34	34.91	31.24
EBITDA Margin %	11.77	14.79	17.29	23.12	30.1
EBITA Margin %	8.12	11.35	13.99	20.1	27.23
EBIT Margin %	7.94	11.13	13.83	19.81	26.36
Income From Continuing Operations Margin %	5.59	7.43	10.07	14.72	18.96
Net Income Margin %	5.59	7.43	10.07	14.72	18.96
Net Avail. For Common Margin %	5.59	7.43	10.07	14.72	18.96
Normalized Net Income Margin	4.77	6.64	8.4	12	16.29
Levered Free Cash Flow Margin	3.4	0.48	1.74	-5.91	8.36
Unlevered Free Cash Flow Margin	3.76	0.81	2.03	-5.17	8.67
Asset Turnover
Asset Turnover	0.69	0.74	0.74	0.74	0.73
Fixed Assets Turnover	2.23	2.35	2.3	2.45	2.74
Receivables Turnover (Average Receivables)	6.95	6.7	6.11	6.8	6.63
Inventory Turnover (Average Inventory)	1.32	1.35	1.31	1.26	1.18
Short Term Liquidity
Current Ratio	1.74	1.89	2.26	1.69	3.38
Quick Ratio	0.64	0.79	1.06	0.75	1.94
Operating Cash Flow to Current Liabilities	0.34	0.3	0.51	0.62	1.37
Days Sales Outstanding (Average Receivables)	52.52	54.49	59.77	53.81	55.08
Days Outstanding Inventory (Average Inventory)	277.07	270.24	277.63	290.27	308.78
Average Days Payable Outstanding	21.24	25.19	24.7	23.6	26.07
Cash Conversion Cycle (Average Days)	308.35	299.54	312.71	320.47	337.79
Long Term Solvency
Total Debt/Equity	20.4	17.45	17.2	22.09	6.49
Total Debt / Total Capital	16.95	14.86	14.68	18.09	6.09
LT Debt/Equity	12.33	10.76	9.87	8.39	5.51
Long-Term Debt / Total Capital	10.24	9.16	8.42	6.88	5.17
Total Liabilities / Total Assets	40.31	36.78	33.88	34.84	28.84
EBIT / Interest Expense	13.52	20.92	30.32	16.88	53.68
EBITDA / Interest Expense	21.7	29.58	40.05	20.48	62.84
(EBITDA - Capex) / Interest Expense	12.22	17.17	25.95	16.48	53.94
Total Debt / EBITDA	1.42	0.98	0.87	0.89	0.21
Net Debt / EBITDA	1.03	0.67	0.33	0.45	-0.42
Total Debt / (EBITDA - Capex)	2.53	1.69	1.34	1.11	0.25
Net Debt / (EBITDA - Capex)	1.84	1.15	0.51	0.56	-0.49
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	12.17	15.19	6.94	14.78	14
Gross Profit, 1 Yr. Growth %	18.2	17.49	8.74	17.19	19.38
EBITDA, 1 Yr. Growth %	48.23	42.22	30.93	53.48	48.67
EBITA, 1 Yr. Growth %	70.05	57.06	40.04	64.89	54.73
EBIT, 1 Yr. Growth %	78.74	61.94	41.31	64.47	51.96
Earnings From Cont. Operations, 1 Yr. Growth %	776	52.97	45.07	67.7	46.87
Net Income, 1 Yr. Growth %	776	52.97	45.07	67.7	46.87
Normalized Net Income, 1 Yr. Growth %	137.3	61.28	44.32	64.04	55.04
Diluted EPS Before Extra, 1 Yr. Growth %	773.13	52.53	45.54	67.45	46.74
Accounts Receivable, 1 Yr. Growth %	7.17	31.05	6.81	-0.49	34.61
Inventory, 1 Yr. Growth %	10.16	7.72	9.71	20.59	3.9
Net Property, Plant and Equip., 1 Yr. Growth %	6.46	11.25	8.08	7.61	-3.54
Total Assets, 1 Yr. Growth %	4.8	8.2	6.63	22.6	9.84
Tangible Book Value, 1 Yr. Growth %	13.01	17.07	12.85	-5.16	30.69
Common Equity, 1 Yr. Growth %	10.37	14.6	11.51	20.82	19.95
Cash From Operations, 1 Yr. Growth %	55.48	-11.11	60.34	81.86	49.79
Capital Expenditures, 1 Yr. Growth %	11.22	36.7	4.03	-16.13	6.15
Levered Free Cash Flow, 1 Yr. Growth %	55.56	-83.57	2.7K	-488.71	-260.74
Unlevered Free Cash Flow, 1 Yr. Growth %	38.06	-74.96	443.75	-392.59	-290.18
Dividend Per Share, 1 Yr. Growth %	-	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	9.37	13.67	10.99	10.79	14.39
Gross Profit, 2 Yr. CAGR %	11.82	17.82	12.43	12.89	18.23
EBITDA, 2 Yr. CAGR %	74.15	46.45	33.35	41.75	50.94
EBITA, 2 Yr. CAGR %	280.19	65.47	43.89	51.96	59.58
EBIT, 2 Yr. CAGR %	781.76	69.85	46.68	52.45	57.95
Earnings From Cont. Operations, 2 Yr. CAGR %	109.28	266.06	48.97	55.98	56.94
Net Income, 2 Yr. CAGR %	109.28	266.06	48.97	55.98	56.94
Normalized Net Income, 2 Yr. CAGR %	332.29	94.98	47.71	53.87	59.33
Diluted EPS Before Extra, 2 Yr. CAGR %	107.76	264.75	48.99	56.11	56.75
Accounts Receivable, 2 Yr. CAGR %	19.68	18.51	18.31	3.09	15.74
Inventory, 2 Yr. CAGR %	6.78	8.93	8.71	15.02	11.94
Net Property, Plant and Equip., 2 Yr. CAGR %	2.13	8.82	9.65	7.84	1.88
Total Assets, 2 Yr. CAGR %	3	6.49	7.41	14.33	16.04
Tangible Book Value, 2 Yr. CAGR %	7.05	15.02	14.94	3.45	11.33
Common Equity, 2 Yr. CAGR %	4.68	12.46	13.04	16.07	20.39
Cash From Operations, 2 Yr. CAGR %	88.29	17.56	19.38	70.76	65.05
Capital Expenditures, 2 Yr. CAGR %	21.78	23.3	19.25	-6.59	-5.64
Levered Free Cash Flow, 2 Yr. CAGR %	26.68	-49.56	-20.28	944.03	150.44
Unlevered Free Cash Flow, 2 Yr. CAGR %	58.72	-41.33	-18.33	298.87	136.41
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.34	11.28	11.38	12.24	11.85
Gross Profit, 3 Yr. CAGR %	13.58	13.66	14.3	13.99	14.98
EBITDA, 3 Yr. CAGR %	80.8	63.72	38.93	39.75	43.95
EBITA, 3 Yr. CAGR %	72.46	185.51	53.4	50.58	52.78
EBIT, 3 Yr. CAGR %	53.49	400.67	56.5	52.39	52.2
Earnings From Cont. Operations, 3 Yr. CAGR %	8.81	88.52	168.88	54.97	52.88
Net Income, 3 Yr. CAGR %	8.81	88.52	168.88	54.97	52.88
Normalized Net Income, 3 Yr. CAGR %	52.08	210.51	72.61	52.97	54.16
Diluted EPS Before Extra, 3 Yr. CAGR %	8.21	87.36	168.53	54.91	52.92
Accounts Receivable, 3 Yr. CAGR %	21.13	23.36	14.47	11.68	12.68
Inventory, 3 Yr. CAGR %	6.63	7.09	9.19	12.54	11.19
Net Property, Plant and Equip., 3 Yr. CAGR %	4.62	5.08	8.57	8.97	3.91
Total Assets, 3 Yr. CAGR %	6.22	4.71	6.53	12.25	12.81
Tangible Book Value, 3 Yr. CAGR %	5.21	10.29	14.3	7.81	11.83
Common Equity, 3 Yr. CAGR %	3.06	7.88	12.15	15.58	17.35
Cash From Operations, 3 Yr. CAGR %	70.15	46.61	30.37	37.36	63.46
Capital Expenditures, 3 Yr. CAGR %	20.05	26.56	16.51	6.05	-2.52
Levered Free Cash Flow, 3 Yr. CAGR %	-0.09	-35.98	-0.54	35.18	460.28
Unlevered Free Cash Flow, 3 Yr. CAGR %	7.77	-14.36	-2.85	24.96	212.06
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.44	9.16	10.6	11.08	12.58
Gross Profit, 5 Yr. CAGR %	3.63	11.44	13.11	13.11	15.86
EBITDA, 5 Yr. CAGR %	-7.56	52.83	60.63	53.13	43.61
EBITA, 5 Yr. CAGR %	-10.83	55.12	61.21	119.19	55.84
EBIT, 5 Yr. CAGR %	-10.51	44.39	50.63	207.35	57.08
Earnings From Cont. Operations, 5 Yr. CAGR %	-4.1	16.22	23.38	74.76	116.79
Net Income, 5 Yr. CAGR %	-4.1	16.22	23.38	74.76	116.79
Normalized Net Income, 5 Yr. CAGR %	-11.48	33.02	50.12	131.46	67.17
Diluted EPS Before Extra, 5 Yr. CAGR %	-6.16	13.65	22.95	74.17	116.51
Accounts Receivable, 5 Yr. CAGR %	14.6	18.57	20	14.81	14.98
Inventory, 5 Yr. CAGR %	12.24	8.19	7.46	10.2	10.28
Net Property, Plant and Equip., 5 Yr. CAGR %	2.2	5.04	6.61	6.18	5.85
Total Assets, 5 Yr. CAGR %	3.97	4.93	6.69	8.46	10.24
Tangible Book Value, 5 Yr. CAGR %	6.25	5.68	9	7.5	13.1
Common Equity, 5 Yr. CAGR %	3.89	3.92	6.94	11.09	15.37
Cash From Operations, 5 Yr. CAGR %	2.93	1.46	47.67	55.83	43.27
Capital Expenditures, 5 Yr. CAGR %	4.02	4.42	19.73	12.08	7.09
Levered Free Cash Flow, 5 Yr. CAGR %	-14.14	-48.48	-8.81	31.59	43.9
Unlevered Free Cash Flow, 5 Yr. CAGR %	-12.89	-42.58	-3.63	37.39	38.65
Dividend Per Share, 5 Yr. CAGR %	-	-	-	-	-